AnalystsLucas WardLucas Ward's Stock Forecasts
AnalystsLucas Ward
Analyst Ranking
Bottom 4%
#4849 out of 5002 analysts
Average Return
-25.85%
Win Rate
38%8 out of 21
Risk vs Reward
Poor
Good
Lucas Ward's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | +106.85% | $2.19 | $4.53 | 2025-04-14 - 2025-09-03 | Buy |
Vivos Therapeutics IncVVOS | +56.75% | $2.89 | $4.53 | 2024-11-19 - 2025-09-03 | Buy |
Liqtech International IncLIQT | +40.29% | $1.50 | $2.11 | 2025-06-15 - 2025-09-03 | Buy |
Vivos Therapeutics IncVVOS | +40.00% | $3.05 | $4.27 | 2024-08-19 - 2025-08-19 | Buy |
Liqtech International IncLIQT | +33.54% | $1.58 | $2.11 | 2025-04-06 - 2025-09-03 | Buy |
Lucas Ward Analyst Color
Get additional color on Lucas Ward's coverage of popular stocks
Lucas Ward's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
60 Degrees Pharmaceuticals IncSXTP | 3 | Buy | $3.00 | +105.48% | Maintains | a day ago |
Liqtech International IncLIQT | 5 | Buy | $3.60 | +70.62% | Maintains | 3 months ago |
Vivos Therapeutics IncVVOS | 3 | Buy | $6.20 | +36.87% | Maintains | 5 months ago |
Heartsciences IncHSCS | 2 | Buy | $14.00 | +306.98% | Maintains | 6 months ago |
Aclarion IncACON | 3 | Buy | $481.00 | +6,580.56% | Maintains | 9 months ago |
Cyclo Therapeutics IncCYTH | 2 | Buy | $0.95 | N/A | Maintains | a year ago |
Vision Marine Technologies IncVMAR | 2 | Buy | $2,700.00 | N/A | Maintains | a year ago |
Shiftpixy IncPIXY | 1 | Buy | $2,160.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.